Cutting edge: Decreased accumulation and regulatory function of CD4 +CD25high T cells in human STAT5b deficiency

Journal of Immunology

Volumn 177, Issue 5, 2006, Pages 2770-2774

  Cohen, Aileen C ^a   Nadeau, Kari C ^a   Tu, Wenwei ^a   Hwa, Vivian ^b   Dionis, Kira ^a   Bezrodnik, Liliana ^c   Teper, Alejandro ^c   Gaillard, Maria ^c   Heinrich, Juan ^c   Krensky, Alan M ^a   Rosenfeld, Ron G ^a,b   Lewis, David B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD40 LIGAND; CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; PERFORIN; STAT5B PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; HOMOZYGOTE; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 33747775187     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.5.2770     Document Type: Article

References (23)

1. Crispi, S., E. Sanzari, J. Monfregola, N. De Felice, G. Fimiani, R. Ambrosio, M. D'Urso, and M. V. Ursini. 2004. Characterization of the human STAT5A and STAT5B promoters: evidence of a positive and negative mechanism of transcriptional regulation. FEBS Lett. 562: 27-34.
2. Teglund, S., C. McKay, E. Schuetz, J. M. van Deursen, D. Stravopodis, D. Wang, M. Brown, S. Bodner, G. Grosveld, and J. N. Ihle. 1998. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93: 841-850.
3. Imada, K., E. T. Bloom, H. Nakajima, J. A. Horvath-Arcidiacono, G. R. Udy, H. W. Davey, and W. J. Leonard. 1998. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J. Exp. Med. 188: 2067-2074.
4. Nakajima, H., X. W. Liu, A. Wynshaw-Boris, L. A. Rosenthal, K. Imada, D. S. Finbloom, L. Hennighausen, and W. J. Leonard. 1997. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Star5a in IL-2-mediated IL-2 receptor α chain induction. Immunity 7: 691-701.
5. Moriggl, R., D. J. Topham, S. Teglund, V. Sexl, C. McKay, D. Wang, A. Hoffmeyer, J. van Deursen, M. Y. Sangster, K. D. Bunting, et al. 1999. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10: 249-259.
6. Kang, J., B. DiBenedetto, K. Narayan, H. Zhao, S. D. Der, and C. A. Chambers. 2004. STAT5 Is required for thymopoiesis in a development stage-specific manner. J. Immunol. 173: 2307-2314.
7. + regulatory T cell homeostasis and the maintenance of self-tolerance. J. Immunol. 171:3435-3441.
8. Snow, J. W., N. Abraham, M. C. Ma, B. G. Herndier, A. W. Pastuszak, and M. A. Goldsmith. 2003. Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice. J. Immunol. 171: 5042-5050.
9. Kovanen, P. E., and W. J. Leonard. 2004. Cytokines and immunodeficiency diseases: critical roles of the γ(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol. Rev. 202: 67-83.
10. Sharfe, N., H. K. Dadi, M. Shahar, and C. M. Roifman. 1997. Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor. Proc. Natl. Acad. Sci. USA 94: 3168-3171.
11. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
12. Malek, T. R., and A. L. Bayer. 2004. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4: 665-674.
13. + regulatory T cell activity: it takes (IL-)two to tango. Eur. J. Immunol. 35: 1336-1341.
14. Cleary, A. M., W. Tu, A. Enright, T. Giffon, R. Dewaal-Malefyt, K. Gutierrez, and D. B. Lewis. 2003. Impaired accumulation and function of memory CD4 T cells in human IL-12 receptor β1 deficiency. J. Immunol. 170: 597-603.
15. Kofoed, E. M., V. Hwa, B. Little, K. A. Woods, C. K. Buckway, J. Tsubaki, K. L. Pratt, L. Bezrodnik, H. Jasper, A. Tepper, et al. 2003. Growth hormone insensitivity associated with a STAT5b mutation. N. Engl. J. Med. 349: 1139-1147.
16. Chia, D. J., E. Subbian, T. M. Buck, V. Hwa, R. G. Rosenfeld, W. R. Skach, U. Shinde, and P. Rotwein. 2006. Aberrant folding of a mutant Stat5b causes growth hormone insensitivity and proteasomal dysfunction. J. Biol. Chem. 281: 6552-6558.
17. Kim, H. P., J. Kelly, and W. J. Leonard. 2001. The basis for IL-2-induced IL-2 receptor α chain gene regulation: importance of two widely separated IL-2 response elements. Immunity 15: 159-172.
18. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352.
19. + regulatory T cells through a STAT dependent mechanism and induces expansion of these cells in vivo. Blood. In press.
20. - T cells. J. Clin. Invest. 112: 1437-1443.
21. + T cells. Clin. Immunol. 115: 10-18.
22. Schubert, L. A., E. Jeffery, Y. Zhang, F. Ramsdell, and S. F. Ziegler. 2001. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276: 37672-37679.
23. Grossman, W. J., J. W. Verbsky, W. Barchet, M. Colonna, J. P. Atkinson, and T. J. Ley. 2004. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21: 589-601.